IRIS
LOPETUSO, Loris Riccardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.333
EU - Europa 1.123
AS - Asia 171
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
SA - Sud America 3
Totale 3.647
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.314
IE - Irlanda 476
SE - Svezia 263
IT - Italia 260
VN - Vietnam 93
DE - Germania 18
CA - Canada 16
GB - Regno Unito 16
IN - India 16
BE - Belgio 15
TW - Taiwan 14
CN - Cina 13
RO - Romania 10
IR - Iran 9
FR - Francia 8
PL - Polonia 8
HK - Hong Kong 6
SG - Singapore 6
EU - Europa 5
HR - Croazia 5
LU - Lussemburgo 5
UA - Ucraina 5
BG - Bulgaria 4
CH - Svizzera 4
JP - Giappone 4
MY - Malesia 4
AT - Austria 3
AU - Australia 3
DK - Danimarca 3
EG - Egitto 3
ES - Italia 3
RU - Federazione Russa 3
AR - Argentina 2
FI - Finlandia 2
LT - Lituania 2
ME - Montenegro 2
MX - Messico 2
NL - Olanda 2
NO - Norvegia 2
SA - Arabia Saudita 2
SC - Seychelles 2
ZA - Sudafrica 2
BN - Brunei Darussalam 1
HU - Ungheria 1
IM - Isola di Man 1
KR - Corea 1
MT - Malta 1
NG - Nigeria 1
PA - Panama 1
RS - Serbia 1
TH - Thailandia 1
TN - Tunisia 1
TR - Turchia 1
VE - Venezuela 1
Totale 3.647
Salva come PNG Salva come JPEG
Città #
Chandler 766
Dublin 476
Princeton 234
Jacksonville 190
Ashburn 168
Altamura 114
Dong Ket 93
Wilmington 85
Ann Arbor 57
Chieti 42
Falls Church 27
Taranto 19
Norwalk 17
Rome 16
Teramo 16
Brussels 15
London 12
Pune 12
New York 11
Xitun 11
Edinburgh 9
Washington 8
Guglionesi 6
Bologna 5
Chicago 5
Cluj-Napoca 5
Dallas 5
San Jose 5
Seattle 5
Tehran 5
Woodbridge 5
Bari 4
Kuala Lumpur 4
Milan 4
Sofia 4
Stockholm 4
Tokyo 4
Toronto 4
Copenhagen 3
Frankfurt am Main 3
Hangzhou 3
Hefei 3
Luxembourg 3
Montale 3
Termoli 3
Zagreb 3
Zurich 3
Alexander 2
Amsterdam 2
Andover 2
Atlanta 2
Boardman 2
Cairo 2
Central 2
Cologne 2
Corvallis 2
Fairfield 2
Greccio 2
Helsinki 2
Hong Kong 2
Houston 2
Jeddah 2
Johannesburg 2
La Plata 2
Madrid 2
Maranello 2
Moscow 2
Mountain View 2
Oslo 2
Podgorica 2
Querétaro City 2
Rijeka 2
Taipei 2
Vilnius 2
Warsaw 2
Alba Iulia 1
Asyut 1
Bandar Seri Begawan 1
Bang Phlat 1
Belgrade 1
Berlin 1
Bilbao 1
Birmingham 1
Brescia 1
Brisbane 1
Bucharest 1
Budapest 1
Caserta 1
Cerro Maggiore 1
Coimbatore 1
Cormeilles-en-Parisis 1
Council Bluffs 1
Denver 1
Distrito Federal 1
Dong-gu 1
Douglas 1
Düsseldorf 1
Erlangen 1
Francavilla Fontana 1
Fremont 1
Totale 2.580
Salva come PNG Salva come JPEG
Nome #
13C-octanoic acid breath test to study gastric emptying time 83
Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease 78
Assessment of crohn’s disease activity: Magnetic resonance enterography in comparison with clinical and endoscopic evaluations 77
Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis 76
Akkermansia muciniphila: Key player in metabolic and gastrointestinal disorders 59
Specific 13C functional pathways as diagnostic targets in gastroenterology breath-tests: tricks for a correct interpretation 56
Bacillus clausii and gut homeostasis: state of the art and future perspectives 53
Tricks for interpreting and making a good report on hydrogen and 13C breath tests 51
Commensal Clostridia: Leading players in the maintenance of gut homeostasis 50
Characterization of sarcopenia in an IBD population attending an Italian gastroenterology tertiary center 49
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide 49
Towards a disease-associated common trait of gut microbiota dysbiosis: The pivotal role of Akkermansia muciniphila 48
Role of yeasts in healthy and impaired gut microbiota: The gut mycome 48
Food components and dietary habits: Keys for a healthy gut microbiota composition 48
Ulcerative colitis 47
Gut microbiota and inflammatory bowel disease: So far so gut! 47
The gastrointestinal microbiome - Functional interference between stomach and intestine 47
High dose amoxicillin-based first line regimen is equivalent to sequential therapy in the eradication of H. Pylori infection 47
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): Preliminary results from a retrospective cohort study 47
Proteobacteria: A common factor in human diseases 46
Role of Helicobacter pylori infection on nutrition and metabolism 46
Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma 45
Bacillus clausii for the treatment of acute diarrhea in children: A systematic review and meta-analysis of randomized controlled trials 44
Locally injected Infliximab ameliorates murine DSS colitis: Differences in serum and intestinal levels of drug between healthy and colitic mice 44
Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease 44
European Crohn's and colitis organisation topical review on treatment withdrawal ['exit strategies'] in inflammatory bowel disease 44
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises from a First Meta-Analysis 44
Gut Virome and Inflammatory Bowel Disease 43
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders 43
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action 43
The innate and adaptive immune system as targets for biologic therapies in inflammatory bowel disease 43
Commentary to “safety, clinical response, and microbiome findings following fecal microbiota transplant in children with inflammatory bowel disease” 42
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab 42
Gut microbiota modulation and mucosal immunity: Focus on Rifaximin 42
Microbiota and inflammatory bowel disease: An update 42
Flexible colonoscopy in mice to evaluate the severity of colitis and colorectal tumors using a validated endoscopic scoring system 42
IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair 42
Gut microbiota profiling and gut-brain crosstalk in children affected by pediatric acute-onset neuropsychiatric syndrome and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections 42
Dietary magnesium alleviates experimental murine colitis through upregulation of the transient receptor potential melastatin 6 channel 42
Prevalence of cervical HPV and attitude towards cervical screening in IBD patients under immunomodulatory treatment: A multidisciplinary management experience 41
Opposing functions of classic and novel IL-1 family members in gut health and disease 40
Bacteriocins and bacteriophages: Therapeutic weapons for gastrointestinal diseases? 40
Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome? 40
The gut barrier: New acquisitions and therapeutic approaches 39
Liver Injury, Endotoxemia, and Their Relationship to Intestinal Microbiota Composition in Alcohol-Preferring Rats 39
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: Where we stand and future perspectives 39
Actinobacteria: A relevant minority for the maintenance of gut homeostasis 39
Considering gut microbiota disturbance in the management of Helicobacter pylori infection 39
The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications 39
Intestinal permeability in physiological and pathological conditions: Major determinants and assessment modalities 38
Human herpesvirus 8-associated colonic Kaposi's sarcoma during vedolizumab treatment in ulcerative colitis: A case report and review of the literature 38
Epidemiology of inflammatory bowel disease in the Republic of San Marino: The “EPIMICI – San Marino” study 38
Infliximab does not increase colonic cancer risk associated to murine chronic colitis 38
Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment 37
Relationship between oral microbiota and periodontal disease: A systematic review 36
Prevalence of severe irritable bowel syndrome among Italian adults. A meta-analysis 36
Microparticles produced by activated platelets carry a potent and functionally active angiogenic signal in subjects with crohn’s disease 36
Gelatin tannate and tyndallized probiotics: a novel approach for treatment of diarrhea 36
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 36
Epidemiological evaluation of acute gastroenteritis and therapeutic approaches in Middle East Countries 35
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions 35
Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for ‘gut barrier protectors’ in IBD? 35
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre 35
Fighting the Hype for Predictors of Efficacy in Inflammatory Bowel Disease 35
The “dica” endoscopic classification for diverticular disease of the colon shows a significant interobserver agreement among community endoscopists 34
Coeliac disease under a microscope: Histological diagnostic features and confounding factors 34
Exploring Bacteroidetes: Metabolic key points and immunological tricks of our gut commensals 33
Beyond the HLA Genes in Gluten-Related Disorders 33
Intestinal gas production and gastrointestinal symptoms: from pathogenesis to clinical implication 32
Epithelial-specific Toll-like Receptor (TLR)5 Activation Mediates Barrier Dysfunction in Experimental Ileitis 32
The therapeutic management of gut barrier leaking: The emerging role for mucosal barrier protectors 32
A modern multidisciplinary approach to the treatment of enterocutaneous fistulas in Crohn’s disease patients 32
A novel model of colitis-associated cancer in SAMP1/YitFc mice with Crohn's disease-like ileitis 31
Microbes and Alzheimer' disease: Lessons from H. Pylori and GUT microbiota 31
Can we predict the efficacy of anti-TNF-α agents? 31
Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis 31
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications 31
Anti-TNF-α-induced psoriasiform lesions in IBD: An abnormal immune activation or a 'patchy cutaneous' immune suppression? 31
Role and mechanisms of action of Escherichia coli nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update 30
Fecal transplantation for ulcerative colitis: current evidence and future applications 30
Assessment of neurological manifestations in hospitalized patients with COVID-19 30
Bariatric procedures and microbiota: patient selection and outcome prediction 30
The use of anti-spasmodics in the treatment of irritable bowel syndrome: Focus on otilonium bromide 28
Skeletal muscle-gut axis: Emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases 28
The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center 28
Changes in admissions, and hospitalization outcomes of IBD patients in an Italian tertiary referral center over a 13-year period 28
Rifaximin for the treatment of irritable bowel syndrome – a drug safety evaluation 27
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 26
A transition clinic model for inflammatory bowel disease between two tertiary care centers: outcomes and predictive factors 26
The use of probiotics in different phases of diverticular disease 25
The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn’s disease 23
Harmful effects and potential benefits of anti-tumor necrosis factor (TNF)-α on the liver 23
Gut microbial flora, prebiotics, and probiotics in IBD: Their current usage and utility 22
Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment 21
Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches 20
Gut microbiota during dietary restrictions: New insights in non-communicable diseases 19
Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: The Picture Is Taking Shape 19
How to face the advent of sars-cov-2 vaccination in ibd patients: Another task for gastroenterologists 19
European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Neurogastroenterology and Motility, and European Society for Paediatric Gastroenterology Hepatology and Nutrition consensus 17
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 16
Totale 3.847
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.043
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.043
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021782 235 4 165 34 59 135 12 10 10 6 16 96
2021/2022705 53 3 3 118 20 16 11 28 54 39 60 300
2022/20231.882 241 337 89 224 95 348 120 143 169 18 81 17
2023/2024754 53 36 47 51 36 186 235 87 14 9 0 0
Totale 4.123